Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Coty is a global beauty company operating prestige fragrance brands (Gucci, Calvin Klein, Marc Jacobs) and mass-market cosmetics (CoverGirl, Rimmel, Sally Hansen). The company generates approximately 60% of revenue from fragrances and 40% from color cosmetics, with significant exposure to European and North American retail channels. Recent performance reflects restructuring challenges, elevated debt from past acquisitions, and market share losses in mass cosmetics to digitally-native competitors.
Coty operates an asset-light model leveraging licensed prestige brands with high gross margins (64.8%) but significant royalty payments and marketing expenses. Revenue depends on retail traffic, department store health, and brand heat. The company earns through wholesale distribution to retailers with limited direct-to-consumer presence. Pricing power varies significantly: prestige fragrances maintain premium positioning with 70%+ gross margins, while mass cosmetics face intense competition with 55-60% margins. Operating leverage is constrained by fixed royalty commitments and marketing spend requirements to maintain brand relevance.
Prestige fragrance sell-through rates in key markets (US department stores, European specialty retail, travel retail recovery)
Mass cosmetics market share trends versus competitors (L'Oréal, Revlon, e.l.f. Beauty) particularly in North American drugstore channel
Debt refinancing announcements and leverage ratio trajectory (current Debt/Equity 1.03x with negative equity)
Brand portfolio rationalization decisions (divestitures, license renewals, new brand acquisitions)
E-commerce penetration rates and direct-to-consumer channel development versus 15-20% current mix
Secular shift to digitally-native beauty brands (Glossier, Fenty, Kylie Cosmetics) bypassing traditional wholesale model and capturing younger consumers with social media marketing
Department store channel decline reducing prestige fragrance distribution as Macy's, Nordstrom close locations and lose traffic to off-price and online
Clean beauty and ingredient transparency trends pressuring reformulation costs and potentially obsoleting existing product portfolios
License concentration risk with Gucci, Calvin Klein, and other key brands representing majority of prestige revenue subject to non-renewal
L'Oréal and Estée Lauder dominating prestige beauty with stronger brand portfolios, digital capabilities, and Asian market presence
E.l.f. Beauty and other value competitors taking mass cosmetics share through TikTok-driven viral marketing and superior product innovation velocity
Amazon and direct-to-consumer brands disintermediating traditional retail relationships and capturing margin
Private equity-backed competitors (Revlon restructuring, Coty's own past PE ownership) creating industry overcapacity
Negative equity position (-$14.5% ROE) limits financial flexibility and increases bankruptcy risk if operations deteriorate further
0.79x current ratio indicates potential liquidity stress requiring continued credit facility access for working capital
Debt/Equity 1.03x understates leverage given negative book value; net debt likely 4-5x EBITDA range creating refinancing vulnerability
Pension and restructuring liabilities from past acquisitions and workforce reductions creating cash outflow obligations
moderate-high - Prestige fragrances are discretionary purchases sensitive to consumer confidence and department store traffic, showing 15-25% revenue volatility during recessions. Mass cosmetics demonstrate more resilience as affordable luxuries but face trade-down pressure to private label. Travel retail exposure (estimated 8-12% of prestige sales) creates additional cyclicality tied to international tourism and airport traffic. European revenue concentration (40-45% of total) links performance to Eurozone GDP growth and consumer spending trends.
Rising rates negatively impact Coty through higher refinancing costs on $3.5B+ debt load, reducing already-thin net margins. Elevated rates also pressure valuation multiples for low-growth consumer staples and reduce consumer discretionary spending on beauty products. However, limited capital intensity (Capex ~3-4% of revenue) minimizes growth investment sensitivity to financing costs. Current negative net margin amplifies interest expense burden.
High credit sensitivity given elevated leverage and negative equity position. Tightening credit conditions increase refinancing risk and covenant pressure. The company requires continued access to credit markets for working capital given 0.79x current ratio. High-yield credit spread widening directly impacts borrowing costs and could trigger covenant discussions. Beauty retail partners' credit health also matters as retailer bankruptcies create bad debt exposure.
value/distressed - 0.4x Price/Sales and 0.6x Price/Book suggest deep value positioning, but negative margins and -54.3% one-year return indicate distressed situation. Attracts turnaround investors betting on restructuring success, debt refinancing, and margin recovery to normalized levels. 12.5% FCF yield appeals to value investors if cash generation proves sustainable. High volatility and execution risk deter quality-focused investors. Recent 48.6% six-month decline suggests capitulation selling and potential contrarian opportunity or value trap depending on operational trajectory.
high - Recent 24.8% three-month decline and 54.3% one-year loss demonstrate extreme volatility. Negative equity, elevated leverage, and restructuring uncertainty create binary outcomes. Beauty sector typically shows moderate volatility, but Coty's operational challenges and financial stress amplify stock swings. Estimated beta likely 1.5-2.0x given distressed characteristics and small-cap liquidity constraints on London listing.